Literature DB >> 17446071

Discovery of heterobicyclic templates for novel metabotropic glutamate receptor subtype 5 antagonists.

Santosh S Kulkarni1, Amy Hauck Newman.   

Abstract

Investigation of a series of heterobicyclic compounds with essential pharmacophoric features of the metabotropic glutamate receptor 5 (mGluR5) antagonists MPEP and MTEP provided novel structural templates with sub-micromolar affinities at the mGluR5.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17446071      PMCID: PMC1973162          DOI: 10.1016/j.bmcl.2007.03.066

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  26 in total

Review 1.  Novel allosteric antagonists shed light on mglu(5) receptors and CNS disorders.

Authors:  W P Spooren; F Gasparini; T E Salt; R Kuhn
Journal:  Trends Pharmacol Sci       Date:  2001-07       Impact factor: 14.819

2.  Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice.

Authors:  C Chiamulera; M P Epping-Jordan; A Zocchi; C Marcon; C Cottiny; S Tacconi; M Corsi; F Orzi; F Conquet
Journal:  Nat Neurosci       Date:  2001-09       Impact factor: 24.884

Review 3.  Discovery and characterization of non-competitive antagonists of group I metabotropic glutamate receptors.

Authors:  F Gasparini; P Floersheim; P J Flor; M Heinrich; W Inderbitzin; D Ott; A Pagano; C Stierlin; N Stoehr; I Vranesic; R Kuhn
Journal:  Farmaco       Date:  2001 Jan-Feb

4.  The non-competitive antagonists 2-methyl-6-(phenylethynyl)pyridine and 7-hydroxyiminocyclopropan[b]chromen-1a-carboxylic acid ethyl ester interact with overlapping binding pockets in the transmembrane region of group I metabotropic glutamate receptors.

Authors:  A Pagano; D Ruegg; S Litschig; N Stoehr; C Stierlin; M Heinrich; P Floersheim; L Prezèau; F Carroll; J P Pin; A Cambria; I Vranesic; P J Flor; F Gasparini; R Kuhn
Journal:  J Biol Chem       Date:  2000-10-27       Impact factor: 5.157

5.  3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-pyridine: a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity.

Authors:  Nicholas D P Cosford; Lida Tehrani; Jeffrey Roppe; Edwin Schweiger; Nicholas D Smith; Jeffrey Anderson; Linda Bristow; Jesse Brodkin; Xiaohui Jiang; Ian McDonald; Sara Rao; Mark Washburn; Mark A Varney
Journal:  J Med Chem       Date:  2003-01-16       Impact factor: 7.446

6.  Design and synthesis of novel heterobiaryl amides as metabotropic glutamate receptor subtype 5 antagonists.

Authors:  Santosh S Kulkarni; Amy Hauck Newman
Journal:  Bioorg Med Chem Lett       Date:  2007-01-04       Impact factor: 2.823

7.  The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice.

Authors:  Neil E Paterson; Svetlana Semenova; Fabrizio Gasparini; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2003-04-08       Impact factor: 4.530

8.  Antitumor benzothiazoles. 14. Synthesis and in vitro biological properties of fluorinated 2-(4-aminophenyl)benzothiazoles.

Authors:  I Hutchinson; M S Chua; H L Browne; V Trapani; T D Bradshaw; A D Westwell; M F Stevens
Journal:  J Med Chem       Date:  2001-04-26       Impact factor: 7.446

9.  L-homocysteine sulfinic acid and other acidic homocysteine derivatives are potent and selective metabotropic glutamate receptor agonists.

Authors:  Qi Shi; Jason E Savage; Sandra J Hufeisen; Laura Rauser; Ewa Grajkowska; Paul Ernsberger; Jarda T Wroblewski; Joseph H Nadeau; Bryan L Roth
Journal:  J Pharmacol Exp Ther       Date:  2003-04       Impact factor: 4.030

10.  Morphine conditioned reward is inhibited by MPEP, the mGluR5 antagonist.

Authors:  P Popik; M Wróbel
Journal:  Neuropharmacology       Date:  2002-12       Impact factor: 5.250

View more
  14 in total

1.  Structure-activity relationships comparing N-(6-methylpyridin-yl)-substituted aryl amides to 2-methyl-6-(substituted-arylethynyl)pyridines or 2-methyl-4-(substituted-arylethynyl)thiazoles as novel metabotropic glutamate receptor subtype 5 antagonists.

Authors:  Santosh S Kulkarni; Mu-Fa Zou; Jianjing Cao; Jeffrey R Deschamps; Alice L Rodriguez; P Jeffrey Conn; Amy Hauck Newman
Journal:  J Med Chem       Date:  2009-06-11       Impact factor: 7.446

2.  Synthesis and SAR of novel, non-MPEP chemotype mGluR5 NAMs identified by functional HTS.

Authors:  Ya Zhou; Alice L Rodriguez; Richard Williams; C David Weaver; P Jeffrey Conn; Craig W Lindsley
Journal:  Bioorg Med Chem Lett       Date:  2009-10-28       Impact factor: 2.823

3.  Structure-activity relationships in a novel series of 7-substituted-aryl quinolines and 5-substituted-aryl benzothiazoles at the metabotropic glutamate receptor subtype 5.

Authors:  Peng Zhang; Mu-Fa Zou; Alice L Rodriguez; P Jeffrey Conn; Amy Hauck Newman
Journal:  Bioorg Med Chem       Date:  2010-03-27       Impact factor: 3.641

4.  Recent advances in the design and development of novel negative allosteric modulators of mGlu(5).

Authors:  Kyle A Emmitte
Journal:  ACS Chem Neurosci       Date:  2011-08-17       Impact factor: 4.418

5.  (3-Cyano-5-fluorophenyl)biaryl negative allosteric modulators of mGlu(5): Discovery of a new tool compound with activity in the OSS mouse model of addiction.

Authors:  Craig W Lindsley; Brittney S Bates; Usha N Menon; Satyawan B Jadhav; Alexander S Kane; Carrie K Jones; Alice L Rodriguez; P Jeffrey Conn; Christopher M Olsen; Danny G Winder; Kyle A Emmitte
Journal:  ACS Chem Neurosci       Date:  2011-08-17       Impact factor: 4.418

6.  Discovery and SAR of novel mGluR5 non-competitive antagonists not based on an MPEP chemotype.

Authors:  Alice L Rodriguez; Richard Williams; Ya Zhou; Stacey R Lindsley; Uyen Le; Mark D Grier; C David Weaver; P Jeffrey Conn; Craig W Lindsley
Journal:  Bioorg Med Chem Lett       Date:  2009-05-03       Impact factor: 2.823

7.  Palladium-catalyzed Suzuki-Miyaura cross-coupling reactions employing dialkylbiaryl phosphine ligands.

Authors:  Ruben Martin; Stephen L Buchwald
Journal:  Acc Chem Res       Date:  2008-11-18       Impact factor: 22.384

8.  Metabotropic glutamate receptor 5 negative allosteric modulators as novel tools for in vivo investigation.

Authors:  Thomas M Keck; Mu-Fa Zou; Peng Zhang; Rebecca P Rutledge; Amy Hauck Newman
Journal:  ACS Med Chem Lett       Date:  2012-05-22       Impact factor: 4.345

Review 9.  Fragile X syndrome: an update on developing treatment modalities.

Authors:  Aileen Healy; Roger Rush; Timothy Ocain
Journal:  ACS Chem Neurosci       Date:  2011-03-22       Impact factor: 4.418

10.  A novel and expedient approach to new thiazoles, thiazolo[3,2-a]pyridines, dihydrothiophenes, and hydrazones incorporating thieno[2,3-b]thiophene moiety.

Authors:  Yahia Nasser Mabkhot; Assem Barakat; Abdullah Mohammad Al-Majid; Abdullah Saleh Alamary; Taleb T Al-Nahary
Journal:  Int J Mol Sci       Date:  2012-04-23       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.